Measurement, Bolt-ons, and Translations

This Core Knowledge Panel (90 min) starts with an introduction to measurement by Brendan Mulhern (University of Technology Sydney), who chairs the Descriptive System Working Group. After this overview, Fanni Rencz (Corvinus University of Budapest) will introduce the concept of bolt-ons (items that supplement the EQ-5D-5L) and Michael Herdman (National University of Singapore) will introduce the translation process. Yifan Ding (Erasmus MC), Aiping Chua (National…

Read More

EQ-5D-Y Indonesia and the Drop-down Method 

Titi Sahidah Fitriana (Erasmus University) will present her studies bringing EQ-5D-Y as a ready to used instrument in Indonesia. Xin Zhang (University Medical Center Groningen) will present a new drop-down method in preference-based health-outcome measurement. After their brief presentations (15 minutes each), they will answer questions from discussants Michael Herdman (National University of Singapore) and Paul Schneider (University of Sheffield) as well as attendees.

Read More

Health Valuation and the EQ-VT 

This Core Knowledge Panel (90 min) starts with an introduction to health valuation by Michał Jakubczyk (SGH Warsaw School of Economics), who chairs the Valuation Working Group. After this overview, Juan Manuel Ramos Goñi (Maths in Health) will describe the EQ-VT valuation protocol. Jonathan Nazari and Rachel Lee-Yin Tan (Network members) will narrate their first hand experiences as EQ-VT interviewers and serve as discussants. After these presentations, attendees will…

Read More

EQ-5D-5L in RCTs and in comparison with EQ-HWB

Jiajun Yan (McMaster University) will present statistical methods for analyzing EQ-5D-5L data in randomized clinical trials. Maja Kuharic (University of Illinois at Chicago) will compare EQ-HWB/EQ-HWB-S with the EQ-5D-5L and other preference-based measures among US informal caregivers. After their brief presentations (15 minutes each), they will answer questions from discussants Yan Feng and Tessa Peasgood (Group members) as well as attendees (~30…

Read More

EQ-5D clinical dashboards and EQ-HWB DCE

At this Student Research Webinar (60 min), Anja Yvonne Bischof (University of St. Gallen, St. Gallen, Switzerland) will present her recent research on the inclusion of the EQ-5D on clinical dashboards in combination with disease-specific patient-reported outcomes measures. Haode Wang (University of Sheffield, Sheffield, United Kingdom) will present on DCE valuation of the EQ-HWB descriptive system in UK and…

Read More

Choice analysis in health valuation

At this Student Research Webinar (60 min), Maksat Jumamyradov (University of South Florida, Tampa, USA) will present his three recent papers on choice analysis in health valuation, describing biases in conditional and mixed logit estimates when preferences are heterogeneous. After his presentation (30 minutes), he will answer questions from David Mott (OHE, London, UK) and Yiting Luo (Centre for Health Economics…

Read More

EQ-5D-Y Singapore and TTO Distortion

Rachel Lee-Yin Tan (National University of Singapore) will present her research on the EQ-5D-Y as a preference-based HRQoL instrument for use in paediatrics in Singapore. Zhongyu Lang (Erasmus University) will present his finding employing episodic future thinking to reduce the distortion of time preference in time trade-off (TTO). After their brief presentations, they will answer…

Read More

Assessing Population Health

This Core Knowledge Panel starts with an introduction to the assessment of population health by Juanita Haagsma (Erasmus MC), who co-chairs the Populations and Health Systems Working Group. After this overview, Fatima Al Sayah (University of Alberta) will introduce the EuroQol – Data for Assessment of Population Health Needs and Instrument Evaluation (EQ-DAPHNIE) project and…

Read More

The Validity of the EQ-5D in Clinical Practice and among Indigenous People

Irene Salvi (University of St. Gallen) will present how differences in design and requirements affect their integration of the EQ-5D and other measures into disease-specific clinical dashboard. Lilla Roy (University of Alberta) will share what she has learned about how valid the EQ-5D-5L might be for Indigenous people living in urban Alberta, Canada. After their…

Read More

How the EuroQol Office can help you

This Core Knowledge Panel (90 min) starts with an introduction to the EuroQol Office by Bernhard Slaap (Executive Director, EuroQol Research Foundation, Rotterdam, the Netherlands). After this overview, James W. Shaw (Executive Director and Head, Patient-Reported Outcomes Assessment, WWHEOR at Bristol Myers Squibb) and Caitlyn T. Solem (Director, Pipeline Strategy, US Oncology Value Evidence and…

Read More